These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10406057)

  • 1. Radiobiological characterization of two human chemotherapy-resistant intermediate grade non-Hodgkin's lymphoma cell lines.
    Aref A; Mohammad R; Yudelev M; Choudhuri R; Strowbridge A; Orton C; al-Katib A
    Radiat Oncol Investig; 1999; 7(3):158-62. PubMed ID: 10406057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutron and photon clonogenic survival curves of two chemotherapy resistant human intermediate-grade non-Hodgkin lymphoma cell lines.
    Aref A; Yudelev M; Mohammad R; Choudhuri R; Orton C; Al-Katib A
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):999-1003. PubMed ID: 10571208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphoma.
    Aref A; Narayan S; Tekyi-Mensah S; Varterasian M; Dan M; Eilender D; Karanes C; al-Katib A
    Radiat Oncol Investig; 1999; 7(3):186-91. PubMed ID: 10406061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation damage repair capacity of primary clonogenic blasts in acute lymphoblastic leukemia.
    Uckun FM; Chandan-Langlie M; Jaszcz W; Obuz V; Waddick K; Song CW
    Cancer Res; 1993 Mar; 53(6):1431-6. PubMed ID: 8443821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic radiosensitivity and repair of sublethal radiation-induced damage in canine osteosarcoma cell lines.
    Fitzpatrick CL; Farese JP; Milner RJ; Salute ME; Rajon DA; Morris CG; Bova FJ; Lurie DM; Siemann DW
    Am J Vet Res; 2008 Sep; 69(9):1197-202. PubMed ID: 18764694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The radiosensitivities of human neuroblastoma in vitro--a comparison of three cell lines].
    Ito H; Nakayama T; Hashimoto S; Masaki E; Hata J
    Gan No Rinsho; 1988 Dec; 34(15):2031-5. PubMed ID: 3230634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effect of hyperthermia at 42 degrees C and irradiation dose of 2 Gy on two rat yolk sac tumor cell lines with different radio-thermosensitivity in vitro.
    Tamaki Y; Mitsuhashi N; Sakurai H; Islam MS; Takahashi T; Akimoto T; Ishikawa H; Saitoh J; Muramatsu H; Niibe H
    Anticancer Res; 2002; 22(6A):3143-8. PubMed ID: 12530057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of thermoradiosensitization in two human melanoma cell lines and one fibroblast cell line by concurrent mild hyperthermia and low-dose-rate irradiation.
    Raaphorst GP; Bussey A; Heller DP; Ng CE
    Radiat Res; 1994 Mar; 137(3):338-45. PubMed ID: 8146277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.
    Chen CI; Roitman D; Tsang R; Stewart AK; Keating A; Crump M
    Bone Marrow Transplant; 2002 Dec; 30(12):885-91. PubMed ID: 12476281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of fludarabine cytotoxicity on non-Hodgkin's lymphoma by pentoxifylline and rituximab.
    Alas S; Bonavida B; Emmanouilides C
    Anticancer Res; 2000; 20(5A):2961-6. PubMed ID: 11062708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular radiosensitivity of primary and metastatic human uveal melanoma cell lines.
    van den Aardweg GJ; Naus NC; Verhoeven AC; de Klein A; Luyten GP
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2561-5. PubMed ID: 12147585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The response of a human tumor cell line to low radiation doses: evidence of enhanced sensitivity.
    Wouters BG; Skarsgard LD
    Radiat Res; 1994 Apr; 138(1 Suppl):S76-80. PubMed ID: 8146333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell adhesion-mediated radioresistance (CAM-RR). Extracellular matrix-dependent improvement of cell survival in human tumor and normal cells in vitro.
    Cordes N; Meineke V
    Strahlenther Onkol; 2003 May; 179(5):337-44. PubMed ID: 12740661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of in vitro radiosensitivity in human bladder cancer cells.
    Barnetson AR; Banasiak D; Fisher RJ; Mameghan H; Ribeiro JC; Brown K; Brown JL; O'Mara SM; Russell PJ
    Radiat Oncol Investig; 1999; 7(2):66-76. PubMed ID: 10333247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the early response protein EGR-1 in human tumour cells after ionizing radiation is correlated with a reduction of repair of lethal lesions and an increase of repair of sublethal lesions.
    Franken NA; Ten Cate R; Van Bree C; Haveman J
    Int J Oncol; 2004 Apr; 24(4):1027-31. PubMed ID: 15010844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of subsequent acute-dose irradiation on cell survival in vitro following low dose-rate exposures.
    Mitchell CR; Joiner MC
    Int J Radiat Biol; 2002 Nov; 78(11):981-90. PubMed ID: 12456285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of radiation dose-rate-sparing effects in human tumor cells by 3-aminobenzamide.
    Kelland LR; Burgess L; Steel GG
    NCI Monogr; 1988; (6):167-71. PubMed ID: 3352760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
    Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.